✦ LIBER ✦

A randomized phase iii protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)

✍ Scribed by Lydia T.Komarnicky; Theodore L Phillips; Karen Martz; Sucha Asbell; Steven Isaacson; Raul Urtasun

Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 630 KB
Volume: 20
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(91)90137-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase III protocol for the

A randomized phase III protocol for the evaluation of misonidazole with radiation in the treatment of patients with brain metastasis (RTOG-7916)

✍ Lydia Komarnicky; Theodore Phillips; Karen Martz; Mohammed Mohiuddin; Luther Bra 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Phase I study of capecitabine in combina

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma

✍ Edgardo Rivera; Christina Meyers; Morris Groves; Vicente Valero; Deborah Francis 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

Radiation therapy alone or combined with

Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: Report of an rtog prospective randomized trial

✍ Joseph R. Simpson; Madeline Bauer; Carlos A. Perez; Todd H. Wasserman; Bahman Em 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 1013 KB

Equivalence of radiation schedules for t

Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis

✍ Richard D. Gelber; Martin Larson; Bruce B. Borgelt; Simon Kramer 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 2 views

Five whole-brain irradiation schedules ranging from 2000 rad in one week to 4000 rad in four weeks were evaluated in 1830 patients with cerebral metastases treated in two randomized studies by the Radiation Therapy Oncology Group. The duration of palliative effectiveness among those patients with fa

A phase III randomized trial of dacarbaz

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma

✍ Sanjiv S. Agarwala; William Ferri; William Gooding; John M. Kirkwood 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## BACKGROUND. Metastatic melanoma is a disease associated with a poor prognosis, and dacarbazine is still the reference agent. The authors conducted a randomized trial to test the benefit of adding tamoxifen to dacarbazine and carboplatin chemotherapy for previously untreated patients with metast

A Phase I/II study of strontium-89 combi

A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases

✍ Lance C. Pagliaro; Ebrahim S. Delpassand; Dallas Williams; Randall E. Millikan; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the maximum tolerated dose and to evaluate the efficacy of gemcitabine given in combination with strontium‐89 to patients with androgen independent prostate carcinoma. ## METHODS Patients with androgen‐independent pr